Cullin-associated NEDD8-dissociated protein 1, a novel interactor of rabphilin-3A, deubiquitylates rabphilin-3A and regulates arginine vasopressin secretion in PC12 cells. 2018

Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8550, Japan.

The molecular mechanism involved in the exocytosis of arginine vasopressin (AVP) is not fully known. Rabphilin-3A has been suggested as a novel autoantigen in infundibulo-neurohypophysitis (LINH), which leads to central diabetes insipidus through insufficient secretion of AVP. However, the role of rabphilin-3A in the pathogenesis of LINH remains unclear. Thus, the aim of the present study was to identify proteins binding rabphilin-3A in the posterior pituitary. Using glutathione S-transferase (GST)-pulldown assays and proteomic analyses, cullin-associated NEDD8-dissociated protein 1 (CAND1) was identified as a rabphilin-3A-binding protein in the posterior pituitary. Co-immunoprecipitation assays indicated that CAND1 interacted endogenously with rabphilin-3A. In addition, immunohistochemistry experiments showed that CAND1 immunoreactivity was detected mainly in the posterior pituitary, intermediate lobe, and the supraoptic nucleus in the hypothalamus, and less in the anterior lobe, partially co-localizing with rabphilin-3A. Overexpression of CAND1 resulted in deubiquitylation of rabphilin-3A in PC12 cells. Moreover, overexpression of CAND1 in PC12 cells co-transfected with AVP enhanced both basal and KCl-stimulated AVP secretion. The findings indicate that CAND1 inhibits the ubiquitylation of rabphilin-3A and positively regulates AVP secretion. These data shed light on a novel potential mechanism involving rabphilin-3A in AVP secretion, and suggest a new role of CAND1 as a regulator of hormone or neurotransmitter secretion.

UI MeSH Term Description Entries
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D010904 Pituitary Gland, Posterior Neural tissue of the pituitary gland, also known as the neurohypophysis. It consists of the distal AXONS of neurons that produce VASOPRESSIN and OXYTOCIN in the SUPRAOPTIC NUCLEUS and the PARAVENTRICULAR NUCLEUS. These axons travel down through the MEDIAN EMINENCE, the hypothalamic infundibulum of the PITUITARY STALK, to the posterior lobe of the pituitary gland. Neurohypophysis,Infundibular Process,Lobus Nervosus,Neural Lobe,Pars Nervosa of Pituitary,Posterior Lobe of Pituitary,Gland, Posterior Pituitary,Infundibular Processes,Lobe, Neural,Lobes, Neural,Nervosus, Lobus,Neural Lobes,Pituitary Pars Nervosa,Pituitary Posterior Lobe,Posterior Pituitary Gland,Posterior Pituitary Glands,Process, Infundibular,Processes, Infundibular
D000072017 Deubiquitinating Enzymes Enzymes that remove UBIQUITIN from a protein substrate, including POLYUBIQUITIN, or from other molecules. Deubiquitinase,Deubiquitinating Enzyme,Deubiquitinases,Enzyme, Deubiquitinating,Enzymes, Deubiquitinating
D000097624 Rabphilin-3A A putative target protein for RAB3A GTP-BINDING PROTEIN. Implicated in regulated secretion, particularly in neurotransmitter release.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D016716 PC12 Cells A CELL LINE derived from a PHEOCHROMOCYTOMA of the rat ADRENAL MEDULLA. PC12 cells stop dividing and undergo terminal differentiation when treated with NERVE GROWTH FACTOR, making the line a useful model system for NERVE CELL differentiation. Pheochromocytoma Cell Line,Cell Line, Pheochromocytoma,Cell Lines, Pheochromocytoma,PC12 Cell,Pheochromocytoma Cell Lines
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D048868 Adaptor Proteins, Signal Transducing A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes Signal Transducing Adaptor Proteins

Related Publications

Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
September 2011, The Journal of biological chemistry,
Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
March 2020, Plant molecular biology,
Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
December 1994, Biochemical and biophysical research communications,
Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
February 1996, Biochemical and biophysical research communications,
Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
June 2017, ACS chemical biology,
Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
January 1994, Biochemical and biophysical research communications,
Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
April 2002, Endocrinology,
Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
September 1996, Molecular and cellular biology,
Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
June 2010, Sports medicine (Auckland, N.Z.),
Kohtaro Nakashima, and Seiji Takeuchi, and Shintaro Iwama, and Atsushi Kiyota, and Yoshinori Yasuda, and Naoko Iwata, and Atsushi Enomoto, and Hiroshi Arima, and Yoshihisa Sugimura
August 2023, Nature communications,
Copied contents to your clipboard!